Author Reply

We are grateful to the authors for their letter about our article on emulation of target trials (TTs) with real-world data to inform health technology assessment (HTA).1 We offer the following response and encourage further debate around this important topic.

Source: Value in Health - December 18, 2023 Category: International Medicine & Public Health Authors: Silvia Moler-Zapata, Andrew Hutchings, Stephen O ’Neill, Richard J. Silverwood, Richard Grieve Tags: Letter to the Editor Source Type: research